Press release
Atopic Dermatitis Treatment Market 2023 - By Industry Insights, Business Outlook, Future Scenarios, Growth And Forecast 2032
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032The Business Research Company's Atopic Dermatitis Global Market Report 2023 identifies high prevalence of atopic dermatitis as the major driver for the Atopic Dermatitis market's growth in the forecast period. Atopic dermatitis, also called eczema, is a skin condition that causes dryness and itchiness of the skin. The increasing prevalence of atopic dermatitis increases the need for diagnosis and treatment of the disease.
The global atopic dermatitis market size is expected to grow from $6.48 billion in 2022 to $7.51 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The atopic dermatitis market is expected to grow to $13.06 billion in 2027 at a CAGR of 14.9%.
Download Free Sample Of Atopic Dermatitis Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp
Major competitors in the Atopic Dermatitis market are Sanofi S.A., Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc.
A key trend in the Atopic Dermatitis market includes product innovations. Major companies in the market are introducing innovative products to strengthen their market position. For instance, in May 2020, Sanofi, a France-based pharmaceutical company, received FDA approval for its novel dupilumab drug Dupixent for the treatment of moderate-to-severe atopic dermatitis. It is the first and only biologic drug to receive approval for treating atopic dermatitis in children between the ages of 6 and 11. Children treated with it achieved clearer skin in just 16 weeks in the phase 3 trial, which was better than topical corticosteroids alone.
Read More On The Global Atopic Dermatitis Market Report Here:
https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report
The Atopic Dermatitis market is segmented -
• By Drug Class: Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes
• By Mode of Administration: Topical, Injectable, Oral
• By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Atopic Dermatitis market.
The Business Research Company's "Global Atopic Dermatitis Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Atopic Dermatitis Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8285
The Table Of Content For The Atopic Dermatitis Market Include:
1. Executive Summary
2. Atopic Dermatitis Market Characteristics
3. Atopic Dermatitis Market Trends And Strategies
4. Atopic Dermatitis Market - Macro Economic Scenario
5. Atopic Dermatitis Market Size And Growth
……………………………
26. Africa Atopic Dermatitis Market
27. Atopic Dermatitis Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Atopic Dermatitis Market
29. Atopic Dermatitis Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis Treatment Market 2023 - By Industry Insights, Business Outlook, Future Scenarios, Growth And Forecast 2032 here
News-ID: 3144369 • Views: …
More Releases from The Business research company
Major Industry Participants Reinforcing Their Presence in the Robotic Biobanking …
The robotic biobanking systems sector is experiencing swift advancements, driven by growing needs in precision medicine and large-scale research initiatives. As automation becomes increasingly integral to laboratory operations, this market is set to expand significantly, offering promising opportunities and innovations in the years ahead. Let's explore the market size projections, key players, emerging trends, and segmentation details shaping this dynamic industry.
Expected Growth in the Robotic Biobanking Systems Market by 2029
The…
Global Trends Overview: The Rapid Evolution of the Regenerative Xenograft Market
The regenerative xenograft market is gaining significant traction as advancements in medical technology and rising healthcare demands continue to drive its expansion. This sector is poised for substantial growth, supported by increasing investments in healthcare infrastructure and the broadening use of xenograft materials in various surgical procedures. Let's explore the current market valuation, key players, emerging trends, and segmentation details shaping the regenerative xenograft landscape.
Projected Market Valuation and Growth Forecast…
Analysis of Key Market Segments Driving the Prismatic Cell Assembly Automation M …
The prismatic cell assembly automation market is on track for remarkable expansion in the coming years, driven by rapid technological advancements and increasing demand across various sectors. As industries seek higher efficiency and automation in battery production, this market is gaining significant traction. Let's explore the market's size, key players, emerging trends, and the segments shaping its growth.
Projected Market Size and Growth Trajectory for Prismatic Cell Assembly Automation
The prismatic cell…
Market Trend Insights: The Impact of Recent Advances on the Plasma Pyrolysis Hyd …
The plasma pyrolysis hydrogen market is positioned for remarkable expansion in the coming years, driven by growing environmental consciousness and technological innovations. This emerging sector offers promising solutions to meet the increasing demand for clean energy by utilizing advanced plasma pyrolysis methods. Let's explore the current market size, key players, influential trends, and segmentation to understand the dynamics shaping this industry.
Projected Growth and Size of the Plasma Pyrolysis Hydrogen Market
The…
More Releases for Atopic
Rising Prevalence Of Atopic Dermatitis Is A Key Catalyst For The Growth Of The A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Atopic Dermatitis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The scope of the atopic dermatitis market has experienced substantial expansion recently, projected to increase from $8.61 billion in 2024 to reach $9.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.7%;…
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
